サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：mRNAワクチン・治療薬の世界市場規模：mRNAタイプ、用途、エンドユーザー、地域別の予測（2022年～2028年）
市場調査レポート
商品コード
1075644

mRNAワクチン・治療薬の世界市場規模：mRNAタイプ、用途、エンドユーザー、地域別の予測（2022年～2028年）

Global mRNA Vaccines & Therapeutics Market Size study, by mRNA Type (Nucleoside-Modified mRNA, Unmodified mRNA and Self-Amplifying mRNA), by Application, by End-user, and Regional Forecasts 2022-2028
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
mRNAワクチン・治療薬の世界市場規模：mRNAタイプ、用途、エンドユーザー、地域別の予測（2022年～2028年）
出版日: 2022年05月10日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のmRNAワクチン・治療薬の市場規模は、2022年～2028年の間の予測期間中に16.8%以上の好調な成長率で成長すると予測されています。

がんの増加やワクチン接種に対する意識の向上などが、mRNAワクチン・治療薬市場の成長の主要な促進要因です。しかし、治療薬に対する要求の高まりが、2022年～2028年の間の予測期間中の市場成長を妨げる見通しです。

当レポートでは、世界のmRNAワクチン・治療薬市場について調査分析し、市場動向、競合情勢、セグメント別・地域別の市場分析、主要企業のプロファイルなど、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 世界のmRNAワクチン・治療薬市場の定義と範囲

第3章 世界のmRNAワクチン・治療薬市場力学

  • mRNAワクチン・治療薬市場影響分析（2020年～2028年）

第4章 世界のmRNAワクチン・治療薬市場業界分析

  • ポーターのファイブフォースモデル
  • PEST分析
  • 投資採用モデル
  • アナリストの推奨事項と結論
  • 主要な投資機会
  • 主要な成功戦略

第5章 リスク評価：COVID-19の影響

    • 業界に対するCOVID-19の全体的な影響の評価
    • COVID-19以前およびCOVID-19後の市場シナリオ

第6章 世界のmRNAワクチン・治療薬市場：mRNAタイプ別

  • 市場スナップショット
  • 市場実績・ポテンシャル分析：mRNAタイプ別
  • 市場推計と予測：mRNAタイプ別（2018年～2028年）
  • サブセグメント分析
    • ヌクレオシド修飾mRNA（modRNA）
    • 未修飾mRNA
    • 自己増幅mRNA

第7章 世界のmRNAワクチン・治療薬市場：用途別

  • 市場スナップショット
  • 市場実績・ポテンシャル分析：用途別
  • 市場推計と予測：用途別（2018年～2028年）
  • サブセグメント分析
    • COVID mRNA用途
    • 非COVID mRNA用途

第8章 世界のmRNAワクチン・治療薬市場：エンドユーザー別

  • 市場スナップショット
  • 市場実績・ポテンシャル分析：エンドユーザー別
  • 市場推計と予測：エンドユーザー別（2018年～2028年）
  • サブセグメント分析
    • 病院・ヘルスケアクリニック
    • 研究組織・研究機関
    • その他

第9章 世界のmRNAワクチン・治療薬市場：地域分析

  • 地域市場のスナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋
  • ラテンアメリカ
    • ブラジル
    • メキシコ
  • その他の地域

第10章 競合情報

  • 主要な市場戦略
  • 企業プロファイル
    • Gennova Biopharmaceuticals Ltd
    • Arcturus Therapeutics Holdings Inc.
    • Providence Therapeutics
    • CureVac N.V.
    • GlaxoSmithKline plc
    • Pantherna Therapeutics GmbH
    • Silence Therapeutics
    • Ethris GmbH
    • BioNTech
    • Versameb AG

第11章 調査プロセス

図表

LIST OF TABLES

  • TABLE 1. Global mRNA Vaccines and Therapeutics market, report scope
  • TABLE 2. Global mRNA Vaccines and Therapeutics market estimates & forecasts by Region 2018-2028 (USD Billion)
  • TABLE 3. Global mRNA Vaccines and Therapeutics market estimates & forecasts by mRNA Type 2018-2028 (USD Billion)
  • TABLE 4. Global mRNA Vaccines and Therapeutics market estimates & forecasts by Application 2018-2028 (USD Billion)
  • TABLE 5. Global mRNA Vaccines and Therapeutics market estimates & forecasts by End User 2018-2028 (USD Billion)
  • TABLE 6. Global mRNA Vaccines and Therapeutics market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 7. Global mRNA Vaccines and Therapeutics market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 8. Global mRNA Vaccines and Therapeutics market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 9. Global mRNA Vaccines and Therapeutics market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 10. Global mRNA Vaccines and Therapeutics market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 11. Global mRNA Vaccines and Therapeutics market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 12. Global mRNA Vaccines and Therapeutics market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 13. Global mRNA Vaccines and Therapeutics market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 14. Global mRNA Vaccines and Therapeutics market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 15. Global mRNA Vaccines and Therapeutics market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 16. U.S. mRNA Vaccines and Therapeutics market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 17. U.S. mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 18. U.S. mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 19. Canada mRNA Vaccines and Therapeutics market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 20. Canada mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 21. Canada mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 22. UK mRNA Vaccines and Therapeutics market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 23. UK mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 24. UK mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 25. Germany mRNA Vaccines and Therapeutics market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 26. Germany mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 27. Germany mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 28. RoE mRNA Vaccines and Therapeutics market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 29. RoE mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 30. RoE mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 31. China mRNA Vaccines and Therapeutics market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 32. China mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 33. China mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 34. India mRNA Vaccines and Therapeutics market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 35. India mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 36. India mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 37. Japan mRNA Vaccines and Therapeutics market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 38. Japan mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 39. Japan mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 40. RoAPAC mRNA Vaccines and Therapeutics market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 41. RoAPAC mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 42. RoAPAC mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 43. Brazil mRNA Vaccines and Therapeutics market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 44. Brazil mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 45. Brazil mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 46. Mexico mRNA Vaccines and Therapeutics market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 47. Mexico mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 48. Mexico mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 49. RoLA mRNA Vaccines and Therapeutics market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 50. RoLA mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 51. RoLA mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 52. Row mRNA Vaccines and Therapeutics market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 53. Row mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 54. Row mRNA Vaccines and Therapeutics market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 55. List of secondary sources, used in the study of global mRNA Vaccines and Therapeutics market
  • TABLE 56. List of primary sources, used in the study of global mRNA Vaccines and Therapeutics market
  • TABLE 57. Years considered for the study
  • TABLE 58. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global RNA Vaccines and Therapeutics market, research methodology
  • FIG 2. Global mRNA Vaccines and Therapeutics market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global mRNA Vaccines and Therapeutics market, key trends 2021
  • FIG 5. Global mRNA Vaccines and Therapeutics market, growth prospects 2022-2028
  • FIG 6. Global mRNA Vaccines and Therapeutics market, porters 5 force model
  • FIG 7. Global mRNA Vaccines and Therapeutics market, pest analysis
  • FIG 8. Global mRNA Vaccines and Therapeutics market, value chain analysis
  • FIG 9. Global mRNA Vaccines and Therapeutics market by segment, 2018 & 2028 (USD Billion)
  • FIG 10. Global mRNA Vaccines and Therapeutics market by segment, 2018 & 2028 (USD Billion)
  • FIG 11. Global mRNA Vaccines and Therapeutics market by segment, 2018 & 2028 (USD Billion)
  • FIG 12. Global mRNA Vaccines and Therapeutics market by segment, 2018 & 2028 (USD Billion)
  • FIG 13. Global mRNA Vaccines and Therapeutics market by segment, 2018 & 2028 (USD Billion)
  • FIG 14. Global mRNA Vaccines and Therapeutics market, regional snapshot 2018 & 2028
  • FIG 15. North America mRNA Vaccines and Therapeutics market 2018 & 2028 (USD Billion)
  • FIG 16. Europe mRNA Vaccines and Therapeutics market 2018 & 2028 (USD Billion)
  • FIG 17. Asia Pacific mRNA Vaccines and Therapeutics market 2018 & 2028 (USD Billion)
  • FIG 18. Latin America mRNA Vaccines and Therapeutics market 2018 & 2028 (USD Billion)
  • FIG 19. Global mRNA Vaccines and Therapeutics market, company market share analysis (2021)
目次

Global mRNA Vaccines & Therapeutics Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than 16.8% over the forecast period 2022-2028. Messenger Ribonucleic Acid (mRNA) is a single protein-coding gene found in the genome that serves as the foundation for protein synthesis in cells. mRNA vaccines and treatments are made in labs utilizing mammalian cells and have favorable immunological characteristics. non-replicating, in vivo self-replicating, Self-amplifying, and in vitro dendritic cell non-replicating mRNA are some of the most frequent forms of vaccines and treatments. They are injected into the body to activate virus-detecting immunological sensors and cause the cells to generate viral antigen proteins. By increasing B- and T-cell responses contribute to improving the body's immunity. The market growth is driven by key factors such as rise in prevalence of cancer and increase in awareness about vaccination. According to Statista, Breast cancer was the most common cancer form in 2020, with roughly 48 women diagnosed per 100,000 people. Prostate cancer had a 12-month prevalence rate of 30.4 per 100,000 people at the time. However, growing demand for therapeutic medicines impedes the growth of the market over the forecast period of 2022-2028.

The key regions considered for the global mRNA Vaccines & Therapeutics Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. in which, North America is leading the market share and is expected to be the fastest growing region in the forecast years. Factors supporting the market growth are the plentiful presence of prominent players & exponentially surging number of COVID-19 patients in the US.

Major market players included in this report are:

  • Arcturus Therapeutics Holdings Inc.
  • Providence Therapeutics
  • CureVac N.V.
  • GlaxoSmithKline plc
  • Pantherna Therapeutics GmbH
  • Silence Therapeutics
  • Ethris GmbH
  • BioNTech
  • Versameb AG
  • Gennova Biopharmaceuticals Ltd

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and mRNA Type offerings of key players. The detailed segments and sub-segment of the market are explained below:

By mRNA Type:

  • Nucleoside-Modified mRNA (modRNA)
  • Unmodified mRNA
  • Self-Amplifying mRNA

By Application:

  • COVID mRNA Application
  • Non-COVID mRNA Application

By End-User:

  • Hospitals & healthcare Clinics
  • Research Organisation & Institutions
  • Others

By Region:

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • ROE
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • RoAPAC
  • Latin America
    • Brazil
    • Mexico
  • Rest of the World

Furthermore, years considered for the study are as follows:

  • Historical year - 2018, 2019, 2020
  • Base year - 2021
  • Forecast period - 2022 to 2028

Target Audience of the Global mRNA vaccines & therapeutics Market in Market Study:

  • Key Consulting Companies & Advisors
  • Large, medium-sized, and small enterprises
  • Venture capitalists
  • Value-Added Resellers (VARs)
  • Third-party knowledge providers
  • Investment bankers
  • Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
    • 1.2.1. mRNA Vaccines and Therapeutics Market, by Region, 2020-2028 (USD Billion)
    • 1.2.2. mRNA Vaccines and Therapeutics Market, by MRNA Type, 2020-2028 (USD Billion)
    • 1.2.3. mRNA Vaccines and Therapeutics Market, by Application, 2020-2028 (USD Billion)
    • 1.2.4. mRNA Vaccines and Therapeutics Market, by End-User, 2020-2028 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global mRNA Vaccines and Therapeutics Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global mRNA Vaccines and Therapeutics Market Dynamics

  • 3.1. mRNA Vaccines and Therapeutics Market Impact Analysis (2020-2028)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Rise in prevalence of cancer
      • 3.1.1.2. Increase in awareness about vaccination
    • 3.1.2. Market Challenges
      • 3.1.2.1. Growing demand for therapeutic medicines
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Developments in the lipid nanoparticle formulations for in-vivo systemic delivery of mRNA

Chapter 4. Global mRNA Vaccines and Therapeutics Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion
  • 4.5. Top investment opportunity
  • 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

    • 5.1.1. Assessment of the overall impact of COVID-19 on the industry
    • 5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global mRNA Vaccines and Therapeutics Market, by MRNA Type

  • 6.1. Market Snapshot
  • 6.2. Global mRNA Vaccines and Therapeutics Market by mRNA Type, Performance - Potential Analysis
  • 6.3. Global mRNA Vaccines and Therapeutics Market Estimates & Forecasts by mRNA Type, 2018-2028 (USD Billion)
  • 6.4. mRNA Vaccines and Therapeutics Market, Sub Segment Analysis
    • 6.4.1. Nucleoside-Modified mRNA (modRNA)
    • 6.4.2. Unmodified mRNA
    • 6.4.3. Self-Amplifying mRNA

Chapter 7. Global mRNA Vaccines and Therapeutics Market, by Application

  • 7.1. Market Snapshot
  • 7.2. Global mRNA Vaccines and Therapeutics Market by Application, Performance - Potential Analysis
  • 7.3. Global mRNA Vaccines and Therapeutics Market Estimates & Forecasts by Application, 2018-2028 (USD Billion)
  • 7.4. mRNA Vaccines and Therapeutics Market, Sub Segment Analysis
    • 7.4.1. COVID mRNA Application
    • 7.4.2. Non-COVID mRNA Application

Chapter 8. Global mRNA Vaccines and Therapeutics Market, by End-User

  • 8.1. Market Snapshot
  • 8.2. Global mRNA Vaccines and Therapeutics Market by End-User, Performance - Potential Analysis
  • 8.3. Global mRNA Vaccines and Therapeutics Market Estimates & Forecasts by End-User, 2018-2028 (USD Billion)
  • 8.4. mRNA Vaccines and Therapeutics Market, Sub Segment Analysis
    • 8.4.1. Hospitals & healthcare Clinics
    • 8.4.2. Research Organisation & Institutions
    • 8.4.3. Others

Chapter 9. Global mRNA Vaccines and Therapeutics Market, Regional Analysis

  • 9.1. mRNA Vaccines and Therapeutics Market, Regional Market Snapshot
  • 9.2. North America mRNA Vaccines and Therapeutics Market
    • 9.2.1. U.S. mRNA Vaccines and Therapeutics Market
      • 9.2.1.1. mRNA Type breakdown estimates & forecasts, 2018-2028
      • 9.2.1.2. Application breakdown estimates & forecasts, 2018-2028
      • 9.2.1.3. End-User breakdown estimates & forecasts, 2018-2028
    • 9.2.2. Canada mRNA Vaccines and Therapeutics Market
  • 9.3. Europe mRNA Vaccines and Therapeutics Market Snapshot
    • 9.3.1. U.K. mRNA Vaccines and Therapeutics Market
    • 9.3.2. Germany mRNA Vaccines and Therapeutics Market
    • 9.3.3. France mRNA Vaccines and Therapeutics Market
    • 9.3.4. Spain mRNA Vaccines and Therapeutics Market
    • 9.3.5. Italy mRNA Vaccines and Therapeutics Market
    • 9.3.6. Rest of Europe mRNA Vaccines and Therapeutics Market
  • 9.4. Asia-Pacific mRNA Vaccines and Therapeutics Market Snapshot
    • 9.4.1. China mRNA Vaccines and Therapeutics Market
    • 9.4.2. India mRNA Vaccines and Therapeutics Market
    • 9.4.3. Japan mRNA Vaccines and Therapeutics Market
    • 9.4.4. Australia mRNA Vaccines and Therapeutics Market
    • 9.4.5. South Korea mRNA Vaccines and Therapeutics Market
    • 9.4.6. Rest of Asia Pacific mRNA Vaccines and Therapeutics Market
  • 9.5. Latin America mRNA Vaccines and Therapeutics Market Snapshot
    • 9.5.1. Brazil mRNA Vaccines and Therapeutics Market
    • 9.5.2. Mexico mRNA Vaccines and Therapeutics Market
  • 9.6. Rest of The World mRNA Vaccines and Therapeutics Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Gennova Biopharmaceuticals Ltd
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. ProductSummary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Arcturus Therapeutics Holdings Inc.
    • 10.2.3. Providence Therapeutics
    • 10.2.4. CureVac N.V.
    • 10.2.5. GlaxoSmithKline plc
    • 10.2.6. Pantherna Therapeutics GmbH
    • 10.2.7. Silence Therapeutics
    • 10.2.8. Ethris GmbH
    • 10.2.9. BioNTech
    • 10.2.10. Versameb AG

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption